Daniel Coleman, the Australian children’s YouTube creator known as Danny Go!, announces the death of his 14-year-old son after a prolonged illness. Multiple reports say the boy dies following a years-long health battle and a more recent cancer diagnosis. NBC News reports that the son succumbs to cancer after battling a rare genetic disorder and that the death comes about five months after he is diagnosed with cancer. The Independent says Coleman announced earlier that the child was diagnosed with stage 3 cancer, with the diagnosis described as occurring in December. 7News Australia similarly reports that Coleman shares the news publicly, expressing grief in his announcement. Across the sources, the key details remain consistent: Coleman is the parent of the child, the child is 14 at the time of death, and the family’s illness includes a rare genetic condition and a cancer diagnosis that progresses over months. The reports focus on Coleman’s public announcement and the timeline from diagnosis to death.
Danny Go! creator Daniel Coleman announces death of his 14-year-old son
Daniel Coleman, the Australian children’s YouTube creator known as Danny Go!, announces the death of his 14-year-old son after a prolonged illness. Multiple reports say the boy dies following a years-...
- Danny Go! creator Daniel Coleman announces the death of his 14-year-old son.
- Reports say the son dies after battling a rare genetic disorder and cancer.
- NBC News states the cancer diagnosis occurs about five months before the death.
- The Independent reports the child is diagnosed with stage 3 cancer in December.
- 7News Australia and other outlets report Coleman’s public announcement expressing his grief.
‘Oh my sweet boy.’
3 months agoDaniel Coleman, the popular children’s YouTuber better known as Danny Go!, announced Friday that his 14-year-old son died, five months after being diagnosed with cancer.“There’s so much I want to say, but I don’t know how yet.
3 months agoIn December, YouTube star announced his son had been diagnosed with Stage 3 cancer
3 months ago
FDA approves Revolution Medicines’ targeted once-daily pill for advanced pancreatic cancer
The U.S. Food and Drug Administration approves Revolution Medicines’ Rasonque (daraxonrasib), a once-daily targeted oral...
Jacob Fearnley helps Britons close in on US Open main draw spot
British player Jacob Fearnley is among the group of Britons who are one win away from qualifying for the US Open men’s s...
UK man undergoes world’s first live AI-assisted brain surgery to remove tumour
A UK patient, Rhys Hibbert, undergoes what is described as the world’s first live AI-assisted brain surgery, during whic...